» Authors » Wouter B L van den Bossche

Wouter B L van den Bossche

Explore the profile of Wouter B L van den Bossche including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 110
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stavrakaki E, Belcaid Z, Balvers R, Vogelezang L, van den Bossche W, Alderliesten D, et al.
Cancers (Basel) . 2025 Feb; 17(4). PMID: 40002198
: Access to high-quality patient-derived brain tumor tissues is instrumental for translational neuro-oncology research. Glioblastoma tumor material resected by ultrasonic aspiration (UA) during surgery offers an abundant source of material;...
2.
Stavrakaki E, van den Bossche W, Vogelezang L, Teodosio C, Mustafa D, van Dongen J, et al.
Cell Rep Methods . 2024 Mar; 4(3):100716. PMID: 38430913
Oncolytic virus (OV) clinical trials have demonstrated remarkable efficacy in subsets of patients with glioblastoma (GBM). However, the lack of tools to predict this response hinders the advancement of a...
3.
van der Pan K, Kassem S, Khatri I, de Ru A, Janssen G, Tjokrodirijo R, et al.
Front Med (Lausanne) . 2022 Oct; 9:997305. PMID: 36237552
Mass spectrometry (MS)-based proteomics profiling has undoubtedly increased the knowledge about cellular processes and functions. However, its applicability for paucicellular sample analyses is currently limited. Although new approaches have been...
4.
van der Pan K, de Bruin-Versteeg S, Damasceno D, Hernandez-Delgado A, van der Sluijs-Gelling A, van den Bossche W, et al.
Front Immunol . 2022 Oct; 13:935879. PMID: 36189252
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FCM) monitoring of IMCs in peripheral blood (PB) has great clinical potential for disease monitoring due...
5.
Damasceno D, Almeida J, Teodosio C, Sanoja-Flores L, Mayado A, Perez-Pons A, et al.
Cancers (Basel) . 2021 Apr; 13(6). PMID: 33810169
Background: Monocyte/macrophages have been shown to be altered in monoclonal gammopathy of undetermined significance (MGUS), smoldering (SMM) and active multiple myeloma (MM), with an impact on the disruption of the...
6.
van den Bossche W, Vincent A, Teodosio C, Koets J, Taha A, Kleijn A, et al.
Brain Commun . 2021 Jan; 3(1):fcaa215. PMID: 33501422
Diagnosis and monitoring of primary brain tumours, brain metastasis and acute ischaemic stroke all require invasive, burdensome and costly diagnostics, frequently lacking adequate sensitivity, particularly during disease monitoring. Monocytes are...
7.
van den Bossche W, Rykov K, Teodosio C, Ten Have B, Knobben B, Sietsma M, et al.
Clin Immunol . 2020 Jan; 213:108344. PMID: 31964597
No abstract available.
8.
Damasceno D, Teodosio C, van den Bossche W, Perez-Andres M, Arriba-Mendez S, Munoz-Bellvis L, et al.
J Allergy Clin Immunol . 2019 Mar; 144(1):320-323.e6. PMID: 30890326
No abstract available.
9.
van den Bossche W, Rykov K, Teodosio C, Ten Have B, Knobben B, Sietsma M, et al.
Clin Immunol . 2018 Oct; 197:224-230. PMID: 30290225
Leukocyte populations quickly respond to tissue damage, but most leukocyte kinetic studies are not based on multiparameter flow cytometry. We systematically investigated several blood leukocyte populations after controlled tissue damage....
10.
van den Bossche W, Kleijn A, Teunissen C, Voerman J, Teodosio C, Noske D, et al.
Neuro Oncol . 2018 May; 20(11):1494-1504. PMID: 29796615
Background: Immunosuppressive protumoral M2 macrophages are important in pathogenesis, progression, and therapy resistance in glioblastoma (GBM) and provide a target for therapy. Recently oncolytic virotherapy in murine models was shown...